KEYMED BIO-B 02162
78.3003.57%( +2.700 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
KEYMED BIO-B (02162) Major Shareholders - Stakes, Shares Held and Changes - cibo
| Shareholder | |||
|---|---|---|---|
| Bo CHENExecutive Director | 25.16% | 75.15M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| 東方證券股份有限公司（DFZQ） | -48.00K | 78.40 | Sold | 14.89M | 4.98% | ||
| 汇添富基金管理股份有限公司 | -48.00K | 78.40 | Sold | 14.89M | 4.98% | ||
| The Goldman Sachs Group, Inc. | 142.50K | -- | Ceased to be notifiable | 14.86M | 4.98% | ||
| 東方證券股份有限公司（DFZQ） | 203.50K | 72.88 | Bought | 15.10M | 5.05% | ||
| 汇添富基金管理股份有限公司 | 203.50K | 72.88 | Bought | 15.10M | 5.05% | ||
| The Goldman Sachs Group, Inc. | 1.90M | -- | Other event (short) | 7.59M | 2.54% | ||
| The Goldman Sachs Group, Inc. | 287.50K | 81.19 | Bought | 14.94M | 5.00% |
This page shows the major shareholders of KEYMED BIO-B (02162) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.
